ZPHC Retatrutide (AQ Pen) 30 mg
ALSO KNOWN AS
- Retatrutide Pen
- Dual GLP-1/GIP Agonist
- GLP-1 Weight Loss Pen
DESCRIPTION
ZPHC Retatrutide (AQ Pen) 30 mg is a ready-to-use, pre-filled aqueous solution featuring a powerful dual GLP-1 and GIP receptor agonist. This innovative formulation promotes enhanced satiety, slows gastric emptying, and improves insulin sensitivity—offering cutting-edge synergy for metabolic support and fat reduction. Delivered via a precision dial-a-dose pen, the product eliminates the need for mixing and ensures accurate titration with every dose.
DOSAGE & ADMINISTRATION
- Total Concentration: 30 mg per pen
• Delivery Format: 60 clicks × 0.5 mg per click
• Suggested Research Titration:
– Start: 0.5 mg weekly
– Increase by 0.5 mg every 4 weeks
– Maximum: 2.5 mg/week as tolerated
• Administration: Subcutaneous injection using dial-a-dose pen
• Pen includes transparent volume window and tamper-evident security
CYCLE USE
Commonly used in long-term weight loss or metabolic correction research. Recommended titration schedule improves tolerance and efficacy. Often combined with lifestyle intervention or other peptide protocols.
PACKAGE CONTENTS
1 pre-filled 30 mg aqueous pen (60 × 0.5 mg clicks)
STORAGE INSTRUCTIONS
• Refrigerate at 2–8°C once opened
• May be kept at up to 25°C for 30 days (e.g., for travel)
• Do not freeze
• Protect from light
